Table 2.
Day 1 | Day 3 | Day 7 | |||||||
Variables | Non-survivor | Survivor | P | Non-survivor | Survivor | P | Non-survivor | Survivor | P |
N | 96 | 494 | \ | 96 | 494 | \ | 96 | 494 | \ |
WBC, ×109/L | 22.68 ± 9.40 | 18.33 ± 7.63 | <0.001 | 10.44 ± 4.97 | 10.66 ± 5.35 | ns | 13.24 ± 8.24 | 11.85 ± 5.34 | ns |
Neutrophil, ×109/L | 19.58 ± 8.17 | 15.70 ± 7.11 | <0.001 | 8.69 ± 4.39 | 8.66 ± 4.82 | ns | 11.23 ± 7.40 | 9.56 ± 4.91 | 0.037 |
Lymphocyte, ×109/L | 1.77 ± 1.85 | 1.44 ± 1.04 | ns | 0.96 ± 0.71 | 1.09 ± 0.54 | 0.038 | 1.14 ± 1.09 | 1.22 ± 0.57 | ns |
RBC, ×1012/L | 4.78 ± 1.05 | 4.87 ± 0.87 | ns | 3.81 ± 0.80 | 4.09 ± 0.78 | 0.001 | 2.90 ± 0.58 | 3.48 ± 0.68 | <0.001 |
Haemoglobin, g/L | 146.8 ± 33.6 | 148.3 ± 26.7 | ns | 117.6 ± 26.0 | 124.3 ± 24.0 | 0.014 | 89.4 ± 17.6 | 105.0 ± 20.5 | <0.001 |
PLT, ×109/L | 141.7 ± 93.7 | 183.2 ± 86.0 | <0.001 | 70.1 ± 42.2 | 129.6 ± 79.0 | <0.001 | 138.7 ± 88.9 | 204.1 ± 99.1 | <0.001 |
PDW, % | 16.67 ± 3.42 | 15.19 ± 3.21 | <0.001 | 18.97 ± 3.05 | 15.71 ± 3.40 | <0.001 | 17.23 ± 3.67 | 13.87 ± 3.07 | <0.001 |
MPV, % | 11.73 ± 1.22 | 11.26 ± 1.50 | 0.001 | 11.85 ± 1.17 | 11.33 ± 1.48 | 0.001 | 12.14 ± 3.23 | 10.80 ± 1.30 | <0.001 |
PPR, ratio | 0.201 ± 0.184 | 0.115 ± 0.115 | <0.001 | 0.407 ± 0.332 | 0.169 ± 0.128 | <0.001 | 0.293 ± 0.892 | 0.093 ± 0.092 | 0.031 |
Values were presented as mean ± SD. MPV, mean platelet volume; ns, no significance; PDW, platelet distribution width; PLT, platelet count; PPR, PDW-to-PLT ratio; RBC, red blood cell; WBC, white blood cell.